(Q34527770)

2 August 2017

1 reference

title

Epidemiology and clinical presentation of hepatocellular carcinoma (English)

1 reference

2 August 2017

1 reference

Adrian M. Di Bisceglie

series ordinal

1

object named as

Adrian M Di Bisceglie

1 reference

2 August 2017

publication date

1 September 2002

1 reference

Journal of Vascular and Interventional Radiology

2 August 2017

published in

1 reference

2 August 2017

volume

13

1 reference

2 August 2017

issue

9 Pt 2

1 reference

2 August 2017

page(s)

S169-71

1 reference

Epidemiology of primary liver cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Increased mortality from liver cancer in England and Wales is not related to hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Does hepatitis C virus infection contribute to hepatocellular carcinoma in hong kong?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Hepatitis B vaccination and hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961783-7

7 January 2021

10.1016/S1051-0443(07)61783-7

Identifiers

DOI

1 reference

2 August 2017

1 reference